Table 3. Medication Frequencies and Initiation Date Relative to AGEP Start Date for Cases in Which a Single Agent Was Suspected and Medication Start Date Was Before or on AGEP Start Datea .
| Medication type | No. (%) |
|---|---|
| β-lactam antimicrobials | 63 (41.7) |
| Amoxicillin | 7 (4.6) |
| Amoxicillin with clavulanic acid | 5 (3.3) |
| Ampicillin with sulbactam | 1 (0.7) |
| Cefalexin | 2 (1.3) |
| Cefazolin | 6 (4.0) |
| Cefepime | 6 (4.0) |
| Cefpodoxime | 2 (1.3) |
| Ceftazidime | 4 (2.6) |
| Ceftriaxone | 6 (4.0) |
| Cefuroxime | 1 (0.7) |
| Ertapenem | 3 (2.0) |
| Meropenem | 1 (0.7) |
| Oxacillin | 2 (1.3) |
| Piperacillin with tazobactam | 17 (11.3) |
| Non–β-lactam antimicrobials | 51 (33.8) |
| Azithromycin | 2 (1.3) |
| Ciprofloxacin | 3 (2.0) |
| Clindamycin | 9 (6.0) |
| Dapsone | 1 (0.7) |
| Daptomycin | 1 (0.7) |
| Doxycycline | 2 (1.3) |
| Levofloxacin | 3 (2.0) |
| Metronidazole | 1 (0.7) |
| Minocycline | 1 (0.7) |
| Moxifloxacin | 1 (0.7) |
| Trimethoprim with sulfamethoxazole | 11 (7.3) |
| Vancomycin | 16 (10.6) |
| Antifungals | 2 (1.3) |
| Nystatin | 1 (0.7) |
| Terbinafine | 1 (0.7) |
| Analgesics | 5 (3.3) |
| Celecoxib | 1 (0.7) |
| Diclofenac sodium with misoprostol | 1 (0.7) |
| Ibuprofen | 1 (0.7) |
| Oxycodone | 1 (0.7) |
| Oxycodone with paracetamol | 1 (0.7) |
| Anticonvulsants | 9 (6.0) |
| Carbamazepine | 1 (0.7) |
| Lamotrigine | 2 (1.3) |
| Levetiracetam | 1 (0.7) |
| Phenytoin | 2 (1.3) |
| Sodium valproate | 1 (0.7) |
| Calcium channel blockers | 5 (3.3) |
| Diltiazem | 3 (2.0) |
| Nicardipine | 1 (0.7) |
| Nifedipine | 1 (0.7) |
| Others | 13 (8.6) |
| Bupropion | 3 (2.0) |
| Brentuximab | 1 (0.7) |
| Hydroxychloroquine | 4 (2.6) |
| Imatinib | 1 (0.7) |
| Metoprolol | 1 (0.7) |
| Montelukast | 1 (0.7) |
| Venlafaxine | 1 (0.7) |
Abbreviation: AGEP, acute generalized exanthematous pustulosis.
a
Total of 151 patients.